» Articles » PMID: 12010997

Characterization of the Mouse Beta Defensin 1, Defb1, Mutant Mouse Model

Overview
Journal Infect Immun
Date 2002 May 16
PMID 12010997
Citations 81
Authors
Affiliations
Soon will be listed here.
Abstract

Beta defensins are small cationic antimicrobial peptides present in the respiratory system which have been proposed to be dysfunctional in the environment of the cystic fibrosis lung. Defb1, a murine homologue to the human beta defensins, has also been found to be expressed in the respiratory system and, in order to examine the function of beta defensins in vivo, gene targeting was used to generate Defb1-deficient (Defb1(tm1Hgu)/Defb1(tm1Hgu) [Defb1(-/-)]) mice. The Defb1 synthetic peptide was shown to have a salt-sensitive antimicrobial activity that was stronger against Staphylococcus aureus than against Escherichia coli or Pseudomonas aeruginosa. Defb1(-/-) mice were found, however, to be effective in the clearance of the cystic fibrosis relevant pathogen S. aureus from the airways after nebulization. Although no overt deleterious phenotype was evident in the Defb1(-/-) mice, the number of mutant mice found to harbor bacteria of the Staphylococcus species in the bladder was significantly higher (P = 0.008) than that of controls, suggesting a role for these peptides in resistance to urinary tract infection.

Citing Articles

Epididymis-specific RNase A family genes regulate fertility and small RNA processing.

Shaffer J, Gupta A, Kharkwal G, Linares E, Holmes A, Katzman S bioRxiv. 2024; .

PMID: 39253511 PMC: 11383283. DOI: 10.1101/2024.08.26.608813.


A Dynamic Interplay of Innate Immune Responses During Urinary Tract Infection.

Naskar M, Choi H Immune Netw. 2024; 24(4):e31.

PMID: 39246616 PMC: 11377947. DOI: 10.4110/in.2024.24.e31.


Secretory leukocyte protease inhibitor protects against severe urinary tract infection in mice.

Rosen A, Lint M, Voelker D, Gilbert N, Tomera C, Santiago-Borges J mBio. 2024; 15(2):e0255423.

PMID: 38270443 PMC: 10865866. DOI: 10.1128/mbio.02554-23.


Intercalated cell function, kidney innate immunity, and urinary tract infections.

Schwaderer A, Rajadhyaksha E, Canas J, Saxena V, Hains D Pflugers Arch. 2024; 476(4):565-578.

PMID: 38227050 DOI: 10.1007/s00424-024-02905-4.


Effects of Superficial Scratching and Engineered Nanomaterials on Skin Gene Profiles and Microbiota in SKH-1 Mice.

Maenpaa K, Ilves M, Zhao L, Alenius H, Sinkko H, Karisola P Int J Mol Sci. 2023; 24(21).

PMID: 37958613 PMC: 10649582. DOI: 10.3390/ijms242115629.


References
1.
Bals R, Wang X, Wu Z, Freeman T, Bafna V, Zasloff M . Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung. J Clin Invest. 1998; 102(5):874-80. PMC: 508952. DOI: 10.1172/JCI2410. View

2.
Morrison G, Davidson D, Kilanowski F, Borthwick D, Crook K, Maxwell A . Mouse beta defensin-1 is a functional homolog of human beta defensin-1. Mamm Genome. 1998; 9(6):453-7. DOI: 10.1007/s003359900795. View

3.
Morrison G, Davidson D, Dorin J . A novel mouse beta defensin, Defb2, which is upregulated in the airways by lipopolysaccharide. FEBS Lett. 1999; 442(1):112-6. DOI: 10.1016/s0014-5793(98)01630-5. View

4.
Wine J . The genesis of cystic fibrosis lung disease. J Clin Invest. 1999; 103(3):309-12. PMC: 407906. DOI: 10.1172/JCI6222. View

5.
Cole A, Dewan P, Ganz T . Innate antimicrobial activity of nasal secretions. Infect Immun. 1999; 67(7):3267-75. PMC: 116505. DOI: 10.1128/IAI.67.7.3267-3275.1999. View